Strengthening the Case for SGLT-2 Inhibitors in Heart Failure: Insights from Real-World Data

Strengthening the Case for SGLT-2 Inhibitors in Heart Failure: Insights from Real-World Data

Agreement: I AgreeBody: Dear Editor, I am writing in response to the recently published study in The BMJ titled “SGLT-2 inhibitors and mortality among patients with heart failure with reduced ejection fraction: linked database study” . This observational study provides valuable insights into the real-world effectiveness of SGLT-2 inhibitors in patients with heart failure with reduced ejection fraction (HFrEF). The study’s findings align with pre…